» Articles » PMID: 27586185

Glycation Induced Generation of Amyloid Fibril Structures by Glucose Metabolites

Overview
Specialty Biochemistry
Date 2016 Sep 3
PMID 27586185
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The non-enzymatic reaction (glycation) of reducing sugars with proteins has received increased interest in dietary and therapeutic research lately. In the present work, the impact of glycation on structural alterations of camel serum albumin (CSA) by different glucose metabolites was studied. Glycation of CSA was evaluated by specific fluorescence of advanced glycation end-products (AGEs) and determination of available amino groups. Further, conformational changes in CSA during glycation were also studied using 8-analino 1-nephthlene sulfonic acid (ANS) binding assay, circular dichroism (CD) and thermal analysis. Intrinsic fluorescence measurement of CSA showed a 22 nm red shift after methylglyoxal treatment, suggesting glycation induced denaturation of CSA. Rayleigh scattering analysis showed glycation induced turbidity and aggregation in CSA. Furthermore, ANS binding to native and glycated-CSA reflected perturbation in the environment of hydrophobic residues. However, CD spectra did not reveal any significant modifications in the secondary structure of the glycated-CSA. Thioflavin T (ThT) fluorescence of CSA increased after glycation, illustrated cross β-structure and amyloid formation. Transmission electron microscopy (TEM) analysis further reaffirms the formation of aggregate and amyloid. In summary, glucose metabolites induced conformational changes in CSA and produced aggregate and amyloid structures.

Citing Articles

Unraveling the Effects of Hexametaphosphate: Insights into Trypsin Aggregation and Structural Reversal.

Malik A, Alamri A, Altwaijry N, Alamro A, Alhomida A, Ayub R ACS Omega. 2025; 9(51):50537-50543.

PMID: 39741823 PMC: 11683647. DOI: 10.1021/acsomega.4c08286.


Stability of Protein Pharmaceuticals: Recent Advances.

Manning M, Holcomb R, Payne R, Stillahn J, Connolly B, Katayama D Pharm Res. 2024; 41(7):1301-1367.

PMID: 38937372 DOI: 10.1007/s11095-024-03726-x.


Glycosylation-related molecular subtypes and risk score of hepatocellular carcinoma: Novel insights to clinical decision-making.

Shi Y, Wang Y, Yang R, Zhang W, Zhang Y, Feng K Front Endocrinol (Lausanne). 2023; 13:1090324.

PMID: 36605944 PMC: 9807760. DOI: 10.3389/fendo.2022.1090324.


Analysis of the Site-Specific Myoglobin Modifications in the Melibiose-Derived Novel Advanced Glycation End-Product.

Gostomska-Pampuch K, Wisniewski J, Sowinski K, Gruszecki W, Gamian A, Staniszewska M Int J Mol Sci. 2022; 23(21).

PMID: 36361822 PMC: 9655033. DOI: 10.3390/ijms232113036.


Integrated Multi-Omics Data Analysis Reveals Associations Between Glycosylation and Stemness in Hepatocellular Carcinoma.

Liu P, Zhou Q, Li J Front Oncol. 2022; 12:913432.

PMID: 35814473 PMC: 9259879. DOI: 10.3389/fonc.2022.913432.